5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within each sector, 5AM invests across multiple therapeutic areas and modalities and evaluates opportunities based on innovative platform technologies, corporate spin-offs and products with shorter development cycles.
Content 5AM shares on this platform is not, and may not be relied on, in any manner, as legal, tax, investment, accounting or other advice or as an offer to sell or a solicitation of an offer to buy an interest in any private fund, special purpose or other investment vehicle sponsored by 5AM Ventures. Content 5AM shares on this platform is not an investment recommendation.
For a full list of all 5AM portfolio companies, please visit: https://5amventures.com/portfolio/
|
|
|
|
|
51-200 employees
View all 5AM Ventures employees
|
|
|
Venture Capital & Private Equity
|
|
|
501 2nd St, San Francisco, California 94107, US
|
|
|
2002
|
The decision makers in 5AM Ventures are Anna Cosslett Yaeger, Bayard Huck, Deborah Palestrant, etc. Click to Find 5AM Ventures decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.